30/03/2026
Most renal cancer cases are asymptomatic.
Clinical trials must still detect them precisely, consistently, and most importantly, early.
In renal oncology studies, imaging defines endpoints, progression, and regulatory confidence.
At Image Core Lab, we provide specialized clinical trial imaging support for renal cancer, built for both drug development and radiology AI / SaMD validation.
What sets our renal oncology expertise apart:
• Subspecialist radiologists with deep oncology focus
• Consistent application of RECIST 1.1, irRC, and protocol-specific criteria
• Centralized reads designed to reduce variability across sites
• Imaging strategies aligned with regulatory expectations and AI-readiness
Whether you are:
– A CRO managing multi-site renal trials
– A sponsor advancing targeted or immuno-oncology therapies
– A medical device or AI company validating renal imaging algorithms
We help ensure imaging data is accurate, reproducible, and submission-ready.
Partner with us for your next renal oncology program
🔗 https://imagecorelab.com/contact-icl/